Sanofi has teamed up with TrialSpark to jointly acquire and advance clinical-stage candidates, leaning on its partner’s tech-enabled drug development capabilities to hustle the programs toward approval.
What a way to take advantage of some great fall weather on Sunday than go for a hike and that is what hundreds of people did for the annual Walk
The alliance will expand Sanofi’s trek into tech-based drug discovery and development platforms.
FSHD is the second most common form of muscular dystrophy after the Duchenne type, and affects around 1 million people worldwide
SPACs might be slowly creeping back. Monday evening, Estrella Biopharma said it was going public via a SPAC deal with TradeUP Acquisition Corp. The deal is set to close in the first half of 2023, and if all goes as planned, the public version of Estrella — dubbed Estrella Immunopharma
Three years after Sumitomo scooped up Roivant’s 46% stake in the publicly traded Myovant $MYOV as part of a 5-company, $3 billion deal, they’re coming back for the whole thing. But these other investors at Myovant want more than what the Japanese pharma company is currently offering to pay at
Viatris has suffered its second stinging loss in as many weeks in its attempt to challenge Merck’s Januvia and Janumet patents. A federal appeals court on Thursday upheld Merck’s patent rights related to the dihydrogen phosphate salt of sitagliptin — an active ingredient in the blockbuster diabetes…
With few new details of what needs fixing, Lupin disclosed last week that the FDA recently sent a warning letter to its Tarapur, India-based site. After an inspection from March 22 to April 4, Lupin disclosed in an April stock filing that it received a Form 483 with four observations,
Amy West joined Novo Nordisk more than a decade ago to oversee marketing strategies and campaigns for its US diabetes portfolio. However, her career path shifted into digital, and she hasn’t looked back. West went from leading Novo’s first digital health strategy in the US to now heading up digital
Setting the Pace: Accelerating the Race for Clinical Research and Drug Development Post-Pandemic Institute for Global Change
Astellas and Pantherna have expanded their November 2021 pact surrounding the latter’s mRNA platform to include a new target organ, the duo announced Tuesday morning, though they did not specify what that target is. German biotech Pantherna is home to two platform technologies — one that designs mRN…
Takeda on Tuesday morning made an announcement that almost 3,000 people with the rare disease known as hypoparathyroidism were fearing. Due to unresolved supply issues and manufacturing woes, Takeda said it will cut its losses and discontinue its hypoparathyroidism drug, known as Natpara (parathyroi…
Cellarity doesn’t have any lead candidates yet. It doesn’t even have a public pipeline. But it’s still attracting new investors. In a third round of financing announced this morning, Cellarity raised $121 million — just $2 million short of its last round — and brought on four new investors, includin…
Pfizer acquired both Xtandi and Talzenna, a PARP inhibitor, in its $14 billion buyout of Medivation in 2016. And in its Phase III TALAPRO-2 study, it combined the two drugs to treat patients with metastatic castration-resistant prostate cancer, or mCRPC for short, comparing them to Xtandi alone. Tue…
Novartis is turning to a winning coach to talk about Leqvio and the struggles of high cholesterol — including his own. Bruce Arians, the retired NFL head coach of the Arizona Cardinals and Super Bowl-winning Tampa Bay Buccaneers, is partnering with the pharma for its “Coaching Cholesterol” digital,…
Our global unicorn tracker allows you to see all the billion-dollar companies formed since 2016. Explore trends in unicorn formation by filtering for geography or date.
Clinical Trial Patient Recruitment Services Market 2022 Share Revenue and Structure Forecast To 2030 | IQVIA, PPD Inc, Veristat | 2022-09-09 06:39:34
The U.S. current-account deficit increased and reached US$ 234.8 billion in Q4 2021. However, the Ca
Our global unicorn tracker allows you to see all the billion-dollar companies formed since 2016. Explore trends in unicorn formation by filtering for geography or date.
Measurement(s) depression • real-world behavior • anxiety • Depressed Mood • physical mobility • daily smartphone usage Technology Type(s) Smartphone Application • GPS navigation system Factor Type(s) depression level, socioeconomic indicators, demographics Sample Characteristic - Organism Homo sapi…